An Open-Label Study of Tolvaptan in the Heart Failure Patients With Volume Overload

被引：1
|
作者：
Fukunami, Masatake [1 ]
Matsuzaki, Masunori [2 ]
Hori, Masatsugu [3 ]
Izumi, Tohru [4 ]
机构：
[1] Ctr Cardiovasc, Osaka, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 755, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[4] Kitasato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa 228, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2010年 / 16卷 / 09期
关键词：
D O I：
10.1016/j.cardfail.2010.07.148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [31] Treatment of volume overload in refractory heart failure
    Sanchez, Emilio
    Rodriguez, Carmen
    Ortega, Teresa
    Diaz-Molina, Beatriz
    Garcia-Cueto, Carmen
    INSUFICIENCIA CARDIACA, 2011, 6 (01) : 19 - 26
  • [32] Efficacy of tolvaptan for patients of heart failure with hypoalbuminemia
    Okabe, T.
    Ebara, S.
    Yamashita, K.
    Yamamoto, M. H.
    Hoshimoto, K.
    Saito, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 9 - 9
  • [33] Experience with tolvaptan in patients with chronic heart failure
    Castillo Bernal, F. J. Francisco Jose
    Morenate Navio, M. C.
    Baeza Garzon, M. F.
    Lopez Granados, A.
    Castillo Dominguez, J. C.
    Carrasco Avalos, F.
    Arizon Munoz, J. M.
    Arizon Del Prado, J. M.
    Segura Saint-Gerons, C.
    De Lezo Cruz-Conde, J. Suarez
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 85 - 85
  • [34] Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up
    Xu, Xiaorong
    Cheng, Jing
    Zhang, Yeping
    Wang, Xin
    Chen, Mulei
    Xu, Lin
    Zhao, Wenshu
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 983 - 992
  • [35] Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial
    Dhar, Minakshi
    Mittal, Kartik
    Parchani, Ashwin
    Sharma, Manu
    Bahurupi, Yogesh
    Kalra, Sanjay
    Bhat, Nowneet Kumar
    BMJ OPEN, 2022, 12 (05):
  • [36] Future Study With Tolvaptan in Acute Heart Failure
    Goldsmith, Steven R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (04) : 467 - 467
  • [37] Immunoadsorption patients with multiple sclerosis:: an open-label pilot study
    Moldenhauer, A
    Haas, J
    Wäscher, C
    Derfuss, T
    Hoffmann, KT
    Kiesewetter, H
    Salama, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 523 - 530
  • [38] Open-label study results of conivaptan in patients with severe hyponatremia
    Wagoner, Lynne E.
    Rosansky, Steven
    Verbalis, Joseph G.
    McNutt, Bruce
    Yan, Bo
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A18 - A18
  • [39] Mycophenolate Mofetil: An open-label study in 42 MS patients
    Vukusic, S
    Ducray, F
    Gignoux, L
    Dubief, FD
    Achiti, I
    Blanc, A
    Confavreux, C
    NEUROLOGY, 2004, 62 (07) : A491 - A491
  • [40] Mycophenolate mofetil: An open-label study in 42 MS patients
    Vukusic, S.
    Ducray, F.
    Gignoux, L.
    Durand-Dubief, F.
    Achiti, I.
    Blanc, S.
    Confavreux, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 122 - 122
12345